Sana Karam/medicine.washu.edu
Feb 8, 2025, 13:50
Sana Karam: Divergent response to radioimmunotherapy is defined by intrinsic features of the TME
Sana Karam, Vice Chair of Translational Research at University of Colorado School of Medicine, shared a post on X about a paper she co-authored with colleagues published in JITC:
“New from Karam Lab.
TME dictates response to RT-IO:
Tumor response vs progression using identical radiation-immunotherapy regimen is independent of cancer cell type but rather mediated by the TME and Tregs accumulation.”
Authors: Jacob Gadwa, Justin Yu, Miles Piper, Maria Amann, Sana Karam et al.
More posts featuring Sana Karam.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 23, 2025, 08:55
Jun 23, 2025, 08:55
Jun 23, 2025, 07:59